Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038454 (
stroke
)
147,016
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ischemic cerebral
stroke
may cause disability and rehabilitation is mainly dependent on long-term exercise. However, this needs many years of consistent application. Even then, it is not certain that patients will see satisfactory recovery of function. In the ischemic
stroke
, disability is attributed to neuron and axon loss resulting in injury to the nervous tract. In the nerve injury model, recovery of function is dependent on axon regeneration and rewiring of the nervous tract, which may be promoted and improved through appropriate drug intervention.
Death receptor 6
(
DR6
), a member of the tumor necrosis factor (TNF) receptor superfamily, negatively regulates neuron, axon and oligodendrocyte survival and hinders axon and oligodendrocyte regeneration. Inhibition of
DR6
has shown neuroprotection in nerve injury models. We hypothesized, therefore, that pharmacological inhibition of
DR6
could be beneficial to the survival of axons and neurons, the regeneration of axons and oligodendrocytes, and the improvement of neurological function after ischemic cerebral
stroke
.
...
PMID:A new therapy for the reduction of axon and neuron loss and promotion of axon and oligodendrocyte regeneration through inhibition of death receptor 6 pathway after ischemic cerebral stroke. 2308 32